Chronic outcome following acute idiosyncratic drug-induced liver injury (DILI) is not yet defined. This prospective, long-term follow-up study aimed to analyze time to liver enzyme resolutions to establish the best definition and risk factors of DILI chronicity. 298 out of 850 patients in the Spanish DILI registry with no pre-existing disease affecting the liver and follow-up to resolution or ⩾1year were analyzed. Chronicity was defined as abnormal liver biochemistry, imaging test or histology one year after DILI recognition. Out of 298 patients enrolled 273 (92%) resolved ⩽1year from DILI recognition and 25 patients (8%) were chronic. Independent risk factors for chronicity were older age [OR: 1.06, p=0.011], dyslipidemia [OR: 4.26, p=0.04...
Drug-induced liver injury (DILI) is increasingly being recognised as a significant cause of both acu...
Drug-induced liver injury (DILI) remains the most common cause of acute liver failure (ALF) in the w...
Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver inju...
Drug-induced liver injury (DILI) has a very variable clinical and biochemical phenotype and differs ...
Drug-induced liver injury (DILI) has a very variable clinical and biochemical phenotype and differs ...
Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that occurs ei...
Idiosyncratic drug-induced liver injury (DILI) is a challenging liver disorder because it can presen...
Although most drug-induced liver injury (DILI) cases resolve after the offending medication is disco...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
To access publisher's full text version of this article click on the hyperlink belowDrug-induced liv...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
Drug induced liver injury (DILI) is a necro-inflammatory liver disease caused by several drugs commo...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
Drug-induced liver injury (DILI) is increasingly being recognised as a significant cause of both acu...
Drug-induced liver injury (DILI) remains the most common cause of acute liver failure (ALF) in the w...
Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver inju...
Drug-induced liver injury (DILI) has a very variable clinical and biochemical phenotype and differs ...
Drug-induced liver injury (DILI) has a very variable clinical and biochemical phenotype and differs ...
Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that occurs ei...
Idiosyncratic drug-induced liver injury (DILI) is a challenging liver disorder because it can presen...
Although most drug-induced liver injury (DILI) cases resolve after the offending medication is disco...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
To access publisher's full text version of this article click on the hyperlink belowDrug-induced liv...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
Drug induced liver injury (DILI) is a necro-inflammatory liver disease caused by several drugs commo...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
Drug-induced liver injury (DILI) is increasingly being recognised as a significant cause of both acu...
Drug-induced liver injury (DILI) remains the most common cause of acute liver failure (ALF) in the w...
Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver inju...